(Q43639078)

25 November 2017

Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals (English)

1 reference

25 November 2017

0 references

1 reference

Dieye TN

1

1 reference

25 November 2017

Sow PS

2

1 reference

25 November 2017

Simonart T

3

1 reference

25 November 2017

Guèye-Ndiaye A

4

1 reference

25 November 2017

Popper SJ

5

1 reference

25 November 2017

Delforge ML

6

1 reference

25 November 2017

Dieye A

7

1 reference

25 November 2017

Sarr AD

8

1 reference

25 November 2017

Crusiaux A

9

1 reference

25 November 2017

Van Vooren JP

10

1 reference

25 November 2017

Devleeschouwer M

11

1 reference

25 November 2017

Kanki P

12

1 reference

25 November 2017

Mboup S

13

1 reference

25 November 2017

Diakhate L

14

1 reference

25 November 2017

Farber CM

15

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

25 November 2017

9

1 reference

inferred from page(s)

published in

Vaccine

1 reference

25 November 2017

20

1 reference

25 November 2017

5-6

1 reference

25 November 2017

905-913

1 reference

Immune activation is a dominant factor in the pathogenesis of African AIDS

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

An inducible transcription factor activates expression of human immunodeficiency virus in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

Cellular transcription factors involved in the regulation of HIV-1 gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

Active nuclear import of human immunodeficiency virus type 1 preintegration complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

Low and stable HIV infection rates in Senegal: natural course of the epidemic or evidence for success of prevention?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

Lessons from the second AIDS virus, HIV-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

Revaccination against tetanus 17 to 20 years after primary vaccination: kinetics of antibody response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

Spontaneous apoptosis and highly active antiretroviral therapy (HAART)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

Activation of virus replication after vaccination of HIV-1-infected individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

Assessments of Plasma HIV RNA and CD4 Cell Counts after Combined Pneumovax® and Tetanus Toxoid Vaccination: No Detectable Increase in HIV Replication 6 Weeks after Immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

The effects of immunization in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

T cell apoptosis in human immunodeficiency virus type 2- and simian immunodeficiency virus-infected macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

Analysis of lymphocyte cell death and apoptosis in HIV-2-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

Time course of antibody response to tetanus toxoid and pneumococcal capsular polysaccharides in patients infected with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900383-8

7 January 2021

10.1016/S0264-410X(01)00383-8

Identifiers

DOI

1 reference

25 November 2017

1 reference